What is Ricardo Berrios's NPI number?

Ricardo Berrios's National Provider Identifier (NPI) is 1730348673, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Ricardo Berrios's specialty?

Ricardo Berrios is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Ricardo Berrios located?

Ricardo Berrios's practice location on file with NPPES is 405 W Bloomingdale Ave, Brandon, FL 33511-7401.

What is Ricardo Berrios's phone number?

The practice phone number listed in the NPPES registry for Ricardo Berrios is (813) 662-3376.

Does Ricardo Berrios accept Medicare?

Ricardo Berrios is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Ricardo Berrios's NPI active?

Yes — Ricardo Berrios's NPI (1730348673) is active in the NPPES registry as of the last update on 2014-06-26.

IndividualActiveAccepts Medicare

Ricardo Berrios, M.D.

NPI 1730348673 · Dermatology Physician · Brandon, FL

Ricardo Berrios, M.D. is a Dermatology Physician provider in Brandon, FL (NPI 1730348673).

Provider details

NPI number: 1730348673
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: M.D.
Sex: Male
Sole proprietor: No

Practice location

405 W Bloomingdale Ave

Brandon, FL 33511-7401

Phone: (813) 662-3376

Fax: (813) 662-3009

Street-level locationGet directions

More FL providers

Mailing address

405 W Bloomingdale Ave

Brandon, FL 33511-7401

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense ME118963 (FL)
Allopathic & Osteopathic Physicians
Student in an Organized Health Care Education/Training Program390200000X
Student, Health Care
General Practice Physician208D00000XLicense 64505 (GA)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Established profile(69/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
18 yrs in NPPES registry
Profile completeness25% of score
83% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
1,943 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	543	$6
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	537	$90
Destruction of Precancer Skin Growth, 1 Growth17000	243	$54
Biopsy of Related Skin Growth, First Growth11102	214	$95
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	132	$126
Biopsy of Related Skin Growth, Each Additional Growth

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 21 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Ketoconazole	140	79
Triamcinolone Acetonide	134	96
Fluocinonide	86	44
Minocycline Hcl	54	26
Fluorouracil	53	42
Imiquimod	47	29
Hydrocortisone	47	34
Clindamycin Phosphate	26	15

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$88 across 3 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2008-06-05
Last updated: 2014-06-26

Frequently asked questions

What is Ricardo Berrios's NPI number?: Ricardo Berrios's National Provider Identifier (NPI) is 1730348673, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Ricardo Berrios's specialty?: Ricardo Berrios is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Ricardo Berrios located?: Ricardo Berrios's practice location on file with NPPES is 405 W Bloomingdale Ave, Brandon, FL 33511-7401.
What is Ricardo Berrios's phone number?: The practice phone number listed in the NPPES registry for Ricardo Berrios is (813) 662-3376.
Does Ricardo Berrios accept Medicare?: Ricardo Berrios is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Ricardo Berrios's NPI active?: Yes — Ricardo Berrios's NPI (1730348673) is active in the NPPES registry as of the last update on 2014-06-26.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	543	$6
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	537	$90
Destruction of Precancer Skin Growth, 1 Growth17000	243	$54
Biopsy of Related Skin Growth, First Growth11102	214	$95
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	132	$126
Biopsy of Related Skin Growth, Each Additional Growth

Drug

Part D claims (2024)

Beneficiaries

Ketoconazole

140

Triamcinolone Acetonide

134

Fluocinonide

Minocycline Hcl

Fluorouracil

Imiquimod

Hydrocortisone

Clindamycin Phosphate

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$88 across 3 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments